Back to today’s briefing

Story perspectives

Dr. Vinay Prasad Takes Helm at FDA, Sparks Biotech Concerns

5/8/2025

26 5

Summary

Story summary

Dr. Vinay Prasad steps into the role of director at the FDA’s Center for Biologics Evaluation and Research, taking over from Dr. Peter Marks. With a reputation for challenging COVID policies, Prasad is set to champion evidence-based practices. His leadership could tighten regulatory oversight, sparking worries in the biotech industry about potential impacts on innovation and approval timelines.

1 of 1

Story summary

Dr. Vinay Prasad steps into the role of director at the FDA’s Center for Biologics Evaluation and Research, taking over from Dr. Peter Marks. With a reputation for challenging COVID policies, Prasad is set to champion evidence-based practices. His leadership could tighten regulatory oversight, sparking worries in the biotech industry about potential impacts on innovation and approval timelines.